Stemcentrx

About:

Stemcentrx provides pharmaceutical services.

Twitter/X: stemcentrx

Top Investors: Sequoia Capital, Fidelity, Founders Fund, Silicon Valley Bank, Capital Group

Description:

Stemcentrx develops therapies that cure and significantly improve survival for cancer patients. It provides disease specific treatments that attack tumors at the roots. Brian Slingerland and Scott J. Dylla founded Stemcentrx in 2008, with its headquarters in South San Francisco in California. Stemcentrx operates as a subsidiary of AbbVie as of June 1, 2016.

Total Funding Amount:

$516M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2008-01-01

Contact Email:

bd(AT)stemcentrx.com

Hub Tags:

Exited Unicorn